LeRomancer&Trédan Lab retweeted
In triple-negative breast cancer, PRMT5 functions as a master transcriptional coregulator of the glucocorticoid receptor regulating cell migration after dexamethasone treatment. PRMT5 acts in this case as a scaffolding protein independently of its catalytic activity to promote HP1g recruitment @PoulardCoralie @CRCL
life-science-alliance.org/co…
LeRomancer&Trédan Lab retweeted
There is currently no predictive marker of response to #tamoxifen, to guide treatment decisions for ERα+ #BreastCancer.
Dr. Muriel Romancer's team identified 🔎 nuclear PRMT5 expression as an independent predictive marker of sensitivity to tamoxifen.
bit.ly/3OrD9N7
LeRomancer&Trédan Lab retweeted
Latest study from M Le Romancer & O Trédan Lab @crcl. Great work with potential clinical application!
👏👏 #breastcancer #research
Online today! Nuclear #PRMT5 is a biomarker of sensitivity to #tamoxifen in ERα+ #breastcancer
By C Poulard, TH Pham, O Trédan, M Le Romancer & colleagues @crcl
🗞️#openaccess: doi.org/10.15252/emmm.202217…







